<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: June 30, 2000
-------------
Check here if Amendment [ ]; Amendment Number:
--------------------------------
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Perseus, L.L.C.
----------------------------------------------------------
Address: The Army and Navy Club Building
----------------------------------------------------------
1627 I Street, N.W., Suite 610
----------------------------------------------------------
Washington, D.C. 20006
----------------------------------------------------------
Form 13F File Number: 028-05587
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Rodd Macklin
----------------------------------------------------------
Title: Chief Financial Officer, Treasurer and Secretary
----------------------------------------------------------
Phone: (202) 452-0101
----------------------------------------------------------
Signature, Place, and Date of Signing:
/s/ RODD MACKLIN Washington, D.C. September 12, 2000
------------------------- ------------------------- -----------------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
[ X ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and
all holdings are reported by other reporting manager(s).)
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
<PAGE> 2
FORM 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
---------------------------
Form 13F Information Table Entry Total: 20
---------------------------
Form 13F Information Table Value Total: $9,717
---------------------------
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
NONE
<PAGE> 3
FORM 13F INFORMATION TABLE
<TABLE>
<CAPTION>
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
---------------- -------------- -------- -------- ------------------- ---------- -------- --------------------
VOTING AUTHORITY
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER --------------------
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
---------------- -------------- -------- -------- ------------------- ---------- -------- --------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Millennium
Pharmaceuticals,
Inc. Common 599902103 $783 7,000 SH SOLE 7,000
--------------------------------------------------------------------------------------------------------------------------
NetObjects, Inc. Common 64114L102 $103 11,236 SH SOLE 11,236
--------------------------------------------------------------------------------------------------------------------------
Quidel Corporation Common 74838J101 $118 22,500 SH SOLE 22,500
--------------------------------------------------------------------------------------------------------------------------
Aurora Biosciences
Corporation Common 051920106 $307 4,500 SH SOLE 4,500
--------------------------------------------------------------------------------------------------------------------------
Alkermes, Inc. Common 01642T108 $589 12,500 SH SOLE 12,500
--------------------------------------------------------------------------------------------------------------------------
CareInsite, Inc. Common 14170M106 $191 10,700 SH SOLE 10,700
--------------------------------------------------------------------------------------------------------------------------
Neurocrine
Biosciences, Inc. Common 64125C109 $1,174 33,000 SH SOLE 33,000
--------------------------------------------------------------------------------------------------------------------------
Johnson & Johnson Common 478160104 $357 3,500 SH SOLE 3,500
--------------------------------------------------------------------------------------------------------------------------
Bristol-Myers
Squibb Company Common 110122108 $379 6,500 SH SOLE 6,500
--------------------------------------------------------------------------------------------------------------------------
Pfizer Inc. Common 717081103 $1,080 22,500 SH SOLE 22,500
--------------------------------------------------------------------------------------------------------------------------
Advanced
Neuromodulation
Systems, Inc. Common 00757T101 $310 18,500 SH SOLE 18,500
--------------------------------------------------------------------------------------------------------------------------
Gilead Sciences,
Inc. Common 375558103 $1,067 15,000 SH SOLE 15,000
--------------------------------------------------------------------------------------------------------------------------
Amgen Inc. Common 031162100 $457 6,500 SH SOLE 6,500
--------------------------------------------------------------------------------------------------------------------------
Neose
Technologies,
Inc. Common 640522108 $1,052 25,000 SH SOLE 25,000
--------------------------------------------------------------------------------------------------------------------------
Insmed
Incorporated Common 457669109 $195 60,000 SH SOLE 60,000
--------------------------------------------------------------------------------------------------------------------------
Parexel
International
Corp. Common 699462107 $96 10,000 SH SOLE 10,000
--------------------------------------------------------------------------------------------------------------------------
McKesson HBOC,
Inc. Common 58155Q103 $314 15,000 SH SOLE 15,000
--------------------------------------------------------------------------------------------------------------------------
Orchid
Biosciences,
Inc. Common 68571P100 $342 9,000 SH SOLE 9,000
--------------------------------------------------------------------------------------------------------------------------
Alexion
Pharmaceuticals,
Inc. Common 015351109 $358 5,000 SH SOLE 5,000
--------------------------------------------------------------------------------------------------------------------------
Biosource
International,
Inc. Common 09066H104 $445 20,000 SH SOLE 20,000
--------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------
[Repeat as necessary]
</TABLE>
